Cargando…
Clinical neurophysiological tests as objective measures for acute and long-term COVID-19
Autores principales: | Seeck, Margitta, Tankisi, Hatice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733941/ https://www.ncbi.nlm.nih.gov/pubmed/36530768 http://dx.doi.org/10.1016/j.cnp.2022.10.002 |
Ejemplares similares
-
The new Handbook Series of Clinical Neurophysiology
por: Ziemann, Ulf, et al.
Publicado: (2021) -
Long-COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Potential neurophysiological biomarkers for these enigmatic entities
por: Versace, Viviana, et al.
Publicado: (2023) -
Myopathy in acute and long-term COVID-19
por: Tankisi, H., et al.
Publicado: (2022) -
Oxaliplatin‐ and docetaxel‐induced polyneuropathy: clinical and neurophysiological characteristics
por: Bennedsgaard, Kristine, et al.
Publicado: (2020) -
Importance of access to epilepsy monitoring units during the COVID-19 pandemic: Consensus statement of the International League against epilepsy and the International Federation of Clinical Neurophysiology()
por: Beniczky, Sándor, et al.
Publicado: (2021)